The Anti-Cancer Effect of A<sub>3</sub> Adenosine Receptor Agonists: A Novel, Targeted Therapy.

The Anti-Cancer Effect of A₃ Adenosine Receptor Agonists: A Novel, Targeted Therapy.

Fishman, P; Jacobson, K A; Ochaion, A; Cohen, S; Bar-Yehuda, S.

Afiliação

Fishman P; Can-Fite BioPharma Ltd., Kiryat-Matalon, Petah -Tikva, 49170, Israel.
Jacobson KA; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Ochaion A; Can-Fite BioPharma Ltd., Kiryat-Matalon, Petah -Tikva, 49170, Israel.
Cohen S; Can-Fite BioPharma Ltd., Kiryat-Matalon, Petah -Tikva, 49170, Israel.
Bar-Yehuda S; Can-Fite BioPharma Ltd., Kiryat-Matalon, Petah -Tikva, 49170, Israel.

Immunol Endocr Metab Agents Med Chem ; 7: 298-303, 2007 Aug.

Article em En | MEDLINE | ID: mdl-34824647